Table 4 |
||||||
|
Laboratory parameters |
||||||
|
Variable |
Group |
N |
Baseline |
End |
Interactions |
P |
|
|
||||||
|
Creatinine kinase - MB (U/L) |
Time × volume effect: |
0.006 |
||||
|
Control 10 ml/kg |
8 |
0.9 ± 0.1 |
1.0 ± 0.2 |
|||
|
Control 20 ml/kg |
8 |
0.9 ± 0.1 |
1.2 ± 0.2 |
ANOVArm high-volume: |
0.001 |
|
|
Endotoxin 10 ml/kg |
8 |
1.0 ± 0.2 |
1.0 ± 0.2 |
|||
|
Endotoxin 20 ml/kg |
7 |
1.0 ± 0.2 |
1.1 ± 0.3 |
|||
|
Peritonitis 10 ml/kg |
8 |
1.1 ± 0.2 |
1.1 ± 0.3 |
|||
|
Peritonitis 20 ml/kg |
8 |
0.8 ± 0.3 |
1.3 ± 0.2 |
|||
|
|
||||||
|
Creatinine (μmol/L) |
Time × model effect: Time × volume effect: |
0.014 0.029 |
||||
|
Control 10 ml/kg |
8 |
87 ± 18 |
78 ± 17 |
ANOVArm Control: |
0.007 |
|
|
Control 20 ml/kg |
8 |
99 ± 13 |
74 ± 24 |
ANOVArm high-volume: |
0.04 |
|
|
Endotoxin 10 ml/kg |
8 |
86 ± 21 |
79 ± 16 |
|||
|
Endotoxin 20 ml/kg |
7 |
85 ± 15 |
74 ± 10 |
|||
|
Peritonitis 10 ml/kg |
8 |
81 ± 10 |
114 ± 31 |
|||
|
Peritonitis 20 ml/kg |
8 |
82 ± 17 |
76 ± 36 |
|||
|
|
||||||
|
ALAT (U/L) |
Time × volume effect: |
0.001 |
||||
|
Control 10 ml/kg |
8 |
18.1 ± 4.3 |
14.8 ± 4.5 |
|||
|
Control 20 ml/kg |
8 |
20.5 ± 10.5 |
11.3 ± 10.6 |
ANOVArm high-volume: |
0.001 |
|
|
Endotoxin 10 ml/kg |
8 |
17 ± 5.2 |
15.1 ± 4.3 |
|||
|
Endotoxin 20 ml/kg |
7 |
19 ± 5.7 |
11.4 ± 2.4 |
|||
|
Peritonitis 10 ml/kg |
8 |
16.9 ± 6.4 |
16.7 ± 11.2 |
|||
|
Peritonitis 20 ml/kg |
8 |
19.5 ± 9.2 |
11.3 ± 5 |
|||
|
|
||||||
|
ASAT (U/L) |
||||||
|
Control 10 ml/kg |
8 |
84 ± 31 |
60 ± 27 |
|||
|
Control 20 ml/kg |
8 |
114 ± 57 |
76 ± 23 |
|||
|
Endotoxin 10 ml/kg |
8 |
96 ± 23 |
86 ± 44 |
|||
|
Endotoxin 20 ml/kg |
7 |
136 ± 84 |
117 ± 23 |
|||
|
Peritonitis 10 ml/kg |
8 |
104 ± 43 |
129 ± 88 |
|||
|
Peritonitis 20 ml/kg |
8 |
101 ± 50 |
100 ± 55 |
|||
|
|
||||||
|
Values are mean ± standard deviation. ALAT = alanine aminotransferase; ASAT = aspartate aminotransferase. |
||||||
|
Brandt et al. Critical Care 2009 13:R186 doi:10.1186/cc8179 |
||||||